This company listing is no longer active
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Churchill Capital Corp VII Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.60 |
| 52 Week High | US$14.90 |
| 52 Week Low | US$9.00 |
| Beta | 0.043 |
| 11 Month Change | -9.86% |
| 3 Month Change | -7.43% |
| 1 Year Change | -7.96% |
| 33 Year Change | -2.54% |
| 5 Year Change | n/a |
| Change since IPO | -9.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVII.U | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -4.0% | 6.5% | 5.1% |
| 1Y | -8.0% | 59.1% | 37.7% |
Return vs Industry: CVII.U underperformed the US Capital Markets industry which returned 33.8% over the past year.
Return vs Market: CVII.U underperformed the US Market which returned 25.4% over the past year.
Price Volatility
| CVII.U volatility | |
|---|---|
| CVII.U Average Weekly Movement | 8.5% |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CVII.U has not had significant price volatility in the past 3 months.
Volatility Over Time: CVII.U's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Matt Klein | www.vii.churchillcapitalcorp.com |
Churchill Capital Corp VII does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Churchill Capital Corp VII Fundamentals Summary
| CVII.U fundamental statistics | |
|---|---|
| Market cap | US$914.73m |
| Earnings (TTM) | US$21.92k |
| Revenue (TTM) | n/a |
Over9,999x
P/E Ratio0.0x
P/S RatioIs CVII.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVII.U income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$21.92k |
| Earnings | US$21.92k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00024 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -23.6% |
How did CVII.U perform over the long term?
See historical performance and comparison